Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Publikováno v:
Clinical Pharmacokinetics
Background Semaglutide, a glucagon-like peptide-1 (GLP-1) analogue, has been co-formulated with the absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) as a tablet for oral administration. This trial (NCT02014259) investigated
Autor:
Martijn J. Schuemie, Jesse A. Berlin, Rachel B. Weinstein, Daniel Fife, Kayur Patel, Amy Matcho, Patrick B. Ryan, Joel N. Swerdel
Publikováno v:
Drug Safety
Introduction Over-the-counter analgesics such as paracetamol and ibuprofen are among the most widely used, and having a good understanding of their safety profile is important to public health. Prior observational studies estimating the risks associa
Autor:
Dorien Groenendaal-van de Meent, Martin den Adel, Jan Noukens, Marloes Schaddelee, A. Alexiev, Sanne Rijnders, Axel Krebs-Brown, L. Mateva
Publikováno v:
Clinical Drug Investigation
Background and Objective Roxadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor in phase III development for the treatment of anaemia associated with chronic kidney disease. This study evaluated the effects of moderate hepatic impairme
Irisin was discovered as a PGC-1a-activated messenger of myocytes that links sedentary lifestyle, obesity, and diabetes. In this study, we investigated the short-term prognostic value of early measurement of irisin concentration in 1530 Han Chinese p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44376b0635b6aedb9100150056b82d31
https://europepmc.org/articles/PMC6277286/
https://europepmc.org/articles/PMC6277286/